Skip to content

Characterization and Validation of the Short Physical Performance Battery in Individuals Diagnosed With Parkinson's Disease

Observational Study for the Functional Characterization of the Population Diagnosed With Parkinson's Disease in Galicia, and Validation of the Short Physical Performance Battery in Individuals Diagnosed With Parkinson's Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07780461
Acronym
PDSPPB
Enrollment
350
Registered
2026-08-21
Start date
2026-08-01
Completion date
2026-12-25
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PARKINSON DISEASE (Disorder)

Keywords

Parkinson´s Disease, Physical Function, Short Physical Performance Battery (SPPB), Functional Assessment, Psychometric Validation

Brief summary

Parkinson's disease (PD) is a progressive neurodegenerative disorder associated with motor and non-motor impairments that affect physical function, mobility, balance, and quality of life. Although Galicia is one of the Spanish regions with a high prevalence of PD, comprehensive information regarding the functional characteristics of this population remains limited. This observational cross-sectional study aims to characterize the sociodemographic, clinical, cognitive, behavioral, and functional profile of individuals with Parkinson's disease in Galicia and to evaluate the validity and reliability of the Short Physical Performance Battery (SPPB) in this population. The findings will provide updated information on the functional status of people with PD in Galicia and support the use of the SPPB as a practical tool for the assessment of physical performance in clinical and research settings.

Detailed description

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by a combination of motor and non-motor symptoms that negatively affect physical function, mobility, independence, and quality of life. Although advances in pharmacological and surgical treatments have improved symptom management, PD remains associated with progressive functional decline. Accurate assessment of physical performance is therefore essential for clinical decision-making, rehabilitation planning, and monitoring disease progression. The Short Physical Performance Battery (SPPB) is a widely used measure of lower-extremity physical performance that evaluates balance, gait speed, and chair-rise ability. The instrument has demonstrated strong psychometric properties in older adults and several chronic conditions; however, evidence regarding its measurement properties in individuals with Parkinson's disease remains limited. This multicenter observational study aims to characterize the functional profile of individuals with Parkinson's disease living in Galicia, Spain, and to evaluate the psychometric properties of the SPPB in this population. The study will examine the reliability, internal consistency, and construct validity of the instrument, as well as its relationship with established measures of disease severity, balance, mobility, dexterity, cognitive status, physical activity, and muscle strength. 6 7 Participants will undergo a comprehensive multidimensional assessment during the ON phase of their antiparkinsonian medication. In addition to conventional clinical and functional evaluations, selected mobility and physical performance tasks will be instrumented using wearable inertial sensor technology to obtain objective kinematic data. A subgroup of participants will complete a second SPPB assessment after a short interval to evaluate test-retest reliability. The results of this study are expected to provide evidence regarding the suitability of the SPPB as a clinical and research tool for assessing physical performance in individuals with Parkinson's disease. Furthermore, the study will offer valuable information about the functional characteristics of people living with PD in Galicia, supporting future rehabilitation strategies and outcome assessment in this population.

Interventions

None listed

Sponsors

University of Vigo
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Parkinson's disease confirmed by a neurologist. * Provision of written informed consent by the participant or, when applicable, by a legally authorized representative.

Exclusion criteria

* Inability to complete the study assessment procedures.

Design outcomes

Primary

MeasureTime frameDescription
Test-Retest Reliability of the SPPBBaseline and 1 weekReliability of the SPPB assessed through repeated administration after a minimum interval of one week using the Intraclass Correlation Coefficient (ICC).
Short Physical Performance Battery (SPPB) Total ScoreBaselineEvaluation of lower-extremity physical performance through balance, gait speed, and chair-rise tasks. Total score ranges from 0 to 12, with higher scores indicating better physical performance.
Internal Consistency of the SPPBBaselineInternal consistency of the three SPPB components assessed using Cronbach's alpha coefficient.
Convergent Construct Validity of the SPPBBaselineCorrelation of SPPB scores with established functional assessment measures (TUG, BBS, and MDS-UPDRS Part III).

Secondary

MeasureTime frameDescription
Ad Hoc Sociodemographic and Clinical Data Collection FormBaselineAn individual case report form was developed to collect the following participant characteristics and clinical data separately: age (years), sex (male/female), time since Parkinson's disease diagnosis (years, calculated from the date of diagnosis), Hoehn and Yahr stage (stage 1-5), comorbidities (presence and type), Parkinson's disease-specific pharmacological treatment (type and route of administration), disease-specific interventions such as deep brain stimulation (presence/absence and type), and physiotherapy treatment (type and frequency).
Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) (Goetz et al., 2008)BaselineThe Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) is a validated scale assessing Parkinson's disease (PD) severity and progression. It evaluates motor and non-motor symptoms. Total scores range from 0 to 272, with higher scores indicating greater disease severity and worse outcomes. The scale has four parts: Part I assesses non-motor experiences of daily living; Part II assesses motor experiences of daily living; Part III is a clinician-administered motor examination assessing rigidity, bradykinesia, gait, posture, balance, and tremor in relation to medication status (ON/OFF); and Part IV assesses motor complications, including dyskinesias and motor fluctuations.
International Physical Activity Questionnaire (IPAQ)BaselineThe International Physical Activity Questionnaire (IPAQ) is a 7-item self-report instrument assessing physical activity during the previous 7 days. Physical activity is expressed as MET-minutes/week, with higher scores indicating greater physical activity. Participants are classified as having low (\<600 MET-min/week), moderate (600-2999 MET-min/week), or high (≥3000 MET-min/week) physical activity levels.
Mini-Mental State Examination (MMSE) (Folstein et al., 1975; Spanish validation: Lobo et al., 1999)BaselineThe Mini-Mental State Examination (MMSE) is a widely used cognitive screening tool designed to assess global cognitive function and detect cognitive impairment or dementia. It is commonly used in both clinical practice and research to monitor cognitive status over time. The MMSE evaluates five cognitive domains: orientation to time and place, immediate memory registration, attention and calculation, language, and visuospatial construction. Total scores range from 0 to 30, with higher scores indicating better cognitive performance. Cognitive impairment is typically classified as normal (24-30), mild (19-23), moderate (10-18), or severe (0-9). Interpretation of results should consider the participant's educational level, as years of formal education may influence performance
Handgrip Strength AssessmentBaselineUpper-limb muscle strength will be assessed using a Saehan SH5001 hydraulic hand dynamometer (Saehan Corporation). Participants will perform the test in either a standing or seated position, with the elbow extended and slightly away from the trunk. Three measurements will be obtained for each hand, and the mean value will be calculated and recorded in kilograms (kg).
Nine-Hole Peg Test (9HPT) (Proud et al., 2019)BaselineThe Nine-Hole Peg Test (9HPT) is a standardized and widely used measure of finger dexterity and upper extremity function. It assesses fine motor coordination by requiring participants to place nine pegs into nine holes on a pegboard and then remove them as quickly as possible, using one hand at a time. During the assessment, participants are seated at a table with the testing apparatus positioned in front of them. The task is performed separately with each hand, typically beginning with the non-dominant hand. The examiner records the time required to complete the task in seconds. Performance is based on completion time, with shorter times indicating greater manual dexterity and better fine motor function.
Berg Balance Scale (BBS) (Qutubuddin et al., 2005)BaselineThe Berg Balance Scale (BBS) is a validated clinical measure of balance performance, functional mobility, and fall risk in individuals with Parkinson's disease. The scale consists of 14 functional tasks that assess balance during sitting, standing, reaching, turning, transfers, and changes in position. Each item is scored on a 5-point scale ranging from 0 (unable to perform) to 4 (performs independently), with a total score ranging from 0 to 56. Higher scores indicate better balance and greater functional independence. Total scores are commonly interpreted as follows: 0-20, high risk of falls and severe dependency; 21-40, moderate risk of falls and moderate dependency; and 41-56, low risk of falls and greater independence. The BBS is widely used in clinical and research settings to evaluate balance impairments and monitor functional outcomes over time.
Timed Up and Go Test (TUG) (Nocera et al., 2013)BaselineThe Timed Up and Go (TUG) test is a validated measure of functional mobility and fall risk in individuals with Parkinson's disease. Participants are instructed to stand up from a chair with armrests, walk 3 meters, turn around, walk back to the chair, and sit down. Performance is assessed by recording the time (seconds) required to complete the task. Shorter completion times indicate better functional mobility, while longer times are associated with a greater risk of falls.

Countries

Spain

Contacts

CONTACTIrimia Mollinedo-Cardalda, PT, PhD
imollinedo@uvigo.es+34986801771
CONTACTEsther Monge-Pereira, PT, PhD
esther.monge@uvigo.es+34986801750
PRINCIPAL_INVESTIGATORIrimia Mollinedo-Cardalda, PT, PhD

Universidade de Vigo

STUDY_CHAIRIris Machado de Oliveira, PT, PhD

Universidade de Vigo

STUDY_CHAIRDiego Férnandez-Vázquez, PT, PhD

Univeridad Rey Juan Carlos

STUDY_CHAIREsther Monge-Pereira, PT, PhD

Universidade de Vigo

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026